Drugs / SKI3246
last change Apr 2014 re-read 3 minutes ago

SKI3246

Developed for
irritable bowel syndrome
Investigated by
SK Chemicals Co., Ltd.

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02079675 Jan 2013 → Mar 2014 irritable bowel syndrome SK Chemicals Co., Ltd. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SKI3246 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02079675 ↗